المؤلفون: Frueh, M., Panje, C. M., Reck, M., Blackhall, F., Califano, R., Cappuzzo, F., Besse, B., Novello, S., Garrido, P., Felip, E., O'Brien, M., Ares, L. Paz, de Marinis, F., Westeel, Virginie, De Ruysscher, D., Putora, P. M.

المصدر: Frueh , M , Panje , C M , Reck , M , Blackhall , F , Califano , R , Cappuzzo , F , Besse , B , Novello , S , Garrido , P , Felip , E , O'Brien , M , Ares , L P , de Marinis , F , Westeel , V , De Ruysscher , D & Putora , P M 2020 , ' Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts ' , Lung Cancer , vol. ....

مصطلحات موضوعية: Small cell lung cancer (SCLC), Second-line chemotherapy, Decision making, Objective consensus, OPEN-LABEL, PHASE-III, TOPOTECAN, CHEMOTHERAPY, MULTICENTER, RECHALLENGE, ETOPOSIDE, SELECTION, OUTCOMES, IASLC

الاتاحة: https://cris.maastrichtuniversity.nl/en/publications/8ed2c981-c41a-4e93-9ca2-5563712f7ed3
https://doi.org/10.1016/j.lungcan.2020.03.024

المؤلفون: L. Paz Ares, Virginie Westeel, Paul Martin Putora, Enriqueta Felip, Mary O'Brien, Dirk De Ruysscher, Fiona H Blackhall, F. De Marinis, Cédric M. Panje, Benjamin Besse, Frederico Cappuzzo, M. Früh, Raffaele Califano, Pilar Garrido, Martin Reck, Silvia Novello

المساهمون: Radiotherapie, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

المصدر: Lung Cancer, 146, 6-11. Elsevier Ireland Ltd

مصطلحات موضوعية: SELECTION, 0301 basic medicine, Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Vincristine, medicine.medical_specialty, Lung Neoplasms, Cyclophosphamide, medicine.medical_treatment, MULTICENTER, Systemic therapy, Second-line chemotherapy, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, IASLC, Medicine, Humans, Decision making, Objective consensus, Small cell lung cancer (SCLC), 610 Medicine & health, Lung cancer, Etoposide, OUTCOMES, Chemotherapy, Performance status, business.industry, CHEMOTHERAPY, OPEN-LABEL, medicine.disease, PHASE-III, Small Cell Lung Carcinoma, RECHALLENGE, 030104 developmental biology, ETOPOSIDE, 030220 oncology & carcinogenesis, Topotecan, Neoplasm Recurrence, Local, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::265f037e7b46ac2e3130515384134f48
http://hdl.handle.net/2318/1753224